Search

everythinglearnresearchcommunity

for

Search:↓

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Some skin diseases and their treatments can negatively affect male fertility.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Environmental and cosmetic factors, including heat, chemicals, and sun exposure, can cause hair loss and damage.

Using a scalp flap for hair transplantation gives denser, faster results than older methods, but it's complex and needs careful planning.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

The method allows for 3D tracking of hair follicle stem cells and shows they can regenerate hair for up to 180 days.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Outside factors like grooming, chemicals, and the environment can damage hair and cause disorders.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Burn scars heal abnormally and more research is needed to find better treatments.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Careful management of blood thinners is crucial for lupus patients with APS.

New technologies help us better understand how skin microbes affect skin diseases.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

White and yellow dots indicate severe female hair loss in dark skin.

Ruxolitinib treatment may cause eyelash growth.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

ILK is essential for skin development, pigmentation, and healing.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

N-acetyl-L-cysteine (NAC) can prevent DNA damage and protect cells from harm.

Mutation in hairless gene may increase hair loss risk.